Skip to main content

Focal Liver Lesions: Magnetic Resonance Imaging-Pathological Correlation

  • Chapter
Contrast Agents in Liver Imaging

Part of the book series: Series in Radiology ((SERA,volume 25))

  • 59 Accesses

Abstract

Magnetic resonance (MR) imaging is becoming the non-invasive imaging technique of choice for the liver. This is due to the recent development of what has been called ‘advanced MR’. Advanced MR imaging includes modern techniques such as gradientecho imaging, fast spin echo imaging and fat suppression, as well as MR contrast agents that improve lesion conspicuity and provide physiological information1,2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Powers C, Ros PR, Stoupis C, Johnson WK, Segel K. Liver neoplasms: magnetic resonance imaging-pathologic correlation. RadioGraphics 1994;14:459–482.

    PubMed  CAS  Google Scholar 

  2. Bydder GM, Steiner RE, Blumgart LH, et al. MR imaging of the liver using short T1 inversion recovery sequences. J Comput Assist Tomogr. 1985;9(6): 1084–9.

    Article  PubMed  CAS  Google Scholar 

  3. Egglin TK, Rummeney E, Stark DD, et al. Hepatic tumors: quantitative tissue characterization with MR imaging. Radiology. 1990;176:107–10.

    PubMed  CAS  Google Scholar 

  4. Hamm B, Fischer E, Taupitz M. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr. 1990; 14(2):205–16.

    Article  PubMed  CAS  Google Scholar 

  5. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. Am J Roentgenol. 1990;155:943–50.

    CAS  Google Scholar 

  6. Hamm B, Vogel TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP — initial clinical results in 40 patients. Radiology. 1922;182:167–74.

    Google Scholar 

  7. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Craig JR, Peters RC, Edmondson HA, eds. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1989.

    Google Scholar 

  8. Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. Am J Roentgenol. 1989; 152:63–72.

    CAS  Google Scholar 

  9. Ros PR, Lubbers PR, Olmsted WW, et al. Hemangioma of the liver: heterogeneous appearance on T2-weighted images. Am J Roentganol. 1987;149:1167–70.

    CAS  Google Scholar 

  10. Stark DD, Felder RC, Wittenberg J, et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. Am J Roentgenol. 1985; 145:213–22.

    CAS  Google Scholar 

  11. Bree RL, Schwab RE, Glazer GM, et al. The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. Radiographics. 1987;7:1153–75.

    PubMed  CAS  Google Scholar 

  12. Yoshida H, Itai Y, Ohtomo K, et al. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA. Radiology. 1989;171:339–42.

    PubMed  CAS  Google Scholar 

  13. Wanless IR, Mawdsley C, Adams R. Pathogenesis of focal nodular hyperplasia. Hepatology. 1985;5:1194–1200.

    Article  PubMed  CAS  Google Scholar 

  14. Mattison GR, Glazer GM, Quint LE, et al. MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. Am J Roentgenol. 1987;148:711–15.

    CAS  Google Scholar 

  15. Butch RJ, Stark DD, Malt RA. MR imaging of hepatic focal nodular hyperplasia. J Comput Assist Tomogr. 1986;10:874–7.

    Article  PubMed  CAS  Google Scholar 

  16. Rummeny E, Weissleder R, Sironi S, et al. Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology. 1989;171:323–6.

    PubMed  CAS  Google Scholar 

  17. Schiebler ML, Kressel HY, Saul SH, et al. MR imaging of focal nodular hyperplasia of the liver. J Comput Assist Tomogr. 1987;11:651–4.

    Article  PubMed  CAS  Google Scholar 

  18. Christopherson WM, Mays ET, Barrows G. A clinicopathologic study of steroid-related tumors. Am J Surg Pathol. 1977;1:31–41.

    Article  PubMed  CAS  Google Scholar 

  19. Goodman ZD, et al. Kupffer cells in hepatocellular adenomas. Am J Surg Pathol. 1987;11:191–6.

    Article  PubMed  CAS  Google Scholar 

  20. Gabata T, Matsui O, Kadoya M, et al. MR imaging of hepatic adenoma. Am J Roentgenol. 1990;155:1009–11.

    CAS  Google Scholar 

  21. Nokes SR, Baker ME, Spritzer CE, et al. Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr. 1988;12:885–7.

    Article  PubMed  CAS  Google Scholar 

  22. Freeney PC, Baron RL, Teefey SA. Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology. 1992;182:143–8.

    Google Scholar 

  23. Itoh K, Nishimura K, Togashi K, et al. Hepatocellular carcinoma: MR imaging. Radiology. 1987;164:21–5.

    PubMed  CAS  Google Scholar 

  24. Moss AA, Goldberg HJ, Stark DD, et al. Hepatic tumors: magnetic resonance and CT appearance. Radiology. 1984; 150:141–7.

    PubMed  CAS  Google Scholar 

  25. Ohtomo K, Itai Y, Furui S, et al. Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Radiology. 1985;155:421–3.

    PubMed  CAS  Google Scholar 

  26. Ros PR, et al. Encapsulated hepatocellular carcinoma: radiologic findings and pathologic correlation. Gastrointest Radiol. 1990;15:233–7.

    Article  PubMed  CAS  Google Scholar 

  27. Fretz CJ, Elizondo G, Weissleder R, et al. Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer. Radiology. 1989;172:393–7.

    PubMed  CAS  Google Scholar 

  28. Titelbaum DS, Hatabu H, Schiebler ML, et al. Fibrolamellar hepatocellular carcinoma: MR appearance. J Comput Assist Tomogr. 1988;12(4):588–91.

    Article  PubMed  CAS  Google Scholar 

  29. Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. Am J Roentgenol. 1992; 158:77–9.

    CAS  Google Scholar 

  30. O’Neil J, Ros PR. Knowing hepatic pathology aids MRI of liver tumors. Diagn Imaging. 1989;Dec:58–67.

    Google Scholar 

  31. Ishak KG, et al. Biliary cystadenoma and cystadenocarcinoma. Cancer. 1977;38:322–38.

    Article  Google Scholar 

  32. Palacios E, Shannon M, Solomon C, et al. Biliary cystadenoma: ultrasound, CT and MRI. Gastrointest Radiol. 1990; 15:313–16.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ros, P.R. (1995). Focal Liver Lesions: Magnetic Resonance Imaging-Pathological Correlation. In: Balzer, T., Hamm, B., Niendorf, HP. (eds) Contrast Agents in Liver Imaging. Series in Radiology, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0477-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0477-7_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4213-0

  • Online ISBN: 978-94-011-0477-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics